CHEST pulmonary最新文献

筛选
英文 中文
Feasibility of Assessing the Abnormal Pediatric Airway Using Rotational Optical Coherence Tomography 使用旋转光学相干断层扫描评估儿童气道异常的可行性
CHEST pulmonary Pub Date : 2025-06-01 DOI: 10.1016/j.chpulm.2024.100120
Sune Rubak MD, PhD , Anne Katrine Bak Poulsen MD , Signe Thim MD , Nagarajan Muthialu MD , Thomas Kjærgaard MD, PhD , Emil Nielsen Holck MD, PhD
{"title":"Feasibility of Assessing the Abnormal Pediatric Airway Using Rotational Optical Coherence Tomography","authors":"Sune Rubak MD, PhD ,&nbsp;Anne Katrine Bak Poulsen MD ,&nbsp;Signe Thim MD ,&nbsp;Nagarajan Muthialu MD ,&nbsp;Thomas Kjærgaard MD, PhD ,&nbsp;Emil Nielsen Holck MD, PhD","doi":"10.1016/j.chpulm.2024.100120","DOIUrl":"10.1016/j.chpulm.2024.100120","url":null,"abstract":"<div><h3>Background</h3><div>Methods currently used to assess and diagnose abnormalities of pediatric airways have several limitations: CT scans involve a risk of ionizing radiation and diagnostic dynamic bronchoscopies have high interobserver variability. Advanced diagnostic methods for evaluating the dynamic airway are needed to enable newer interventions (eg, airway stenting) in select children. The study objective was to investigate the feasibility of optical coherence tomography (OCT) as a measuring method that facilitates accurate, quantifiable, and real-time cross-sectional imaging of the airway.</div></div><div><h3>Research Question</h3><div>Is bronchoscopy-guided quantitative OCT of the lower pediatric airway a feasible method and does it increase diagnostic possibilities?</div></div><div><h3>Study Design and Methods</h3><div>We evaluated a series of 10 children with severe persistent respiratory symptoms with a clinical indication for diagnostic dynamic bronchoscopy (DDB). Feasibility of OCT was defined as the ability to visualize and quantify airway stenoses and dynamic airway collapse in the pediatric airway without procedural complications. Furthermore, the study included a porcine model to calculate the correction constant for the OCT measurements in air in comparison with contrast fluid.</div></div><div><h3>Results</h3><div>Nine children aged 0 to 14 years were included. In total, 34 airway segments were OCT scanned. Results showed that OCT is a feasible method for visualizing and quantifying stenoses of the lower pediatric airway by measuring the mean and minimum lumen areas. The correction constant of OCT in air was 1.3 (interquartile range, 1.29-1.31) in comparison with contrast. Visual assessment of the minimum lumen area stenosis by dynamic bronchoscopy significantly varies in comparison with OCT assessment (18.416%; 95% CI, 8.93-27.91; <em>P</em> = .0018).</div></div><div><h3>Interpretation</h3><div>OCT demonstrated feasibility of providing quantitative assessments of clinical manifestations including cross-sectional imaging in the pediatric airway. The correction constant for optimal quantification was calculated and provided the possibility for precise interpretation of OCT measurements. Further studies are needed to investigate safety, accuracy, and efficacy of OCT in the lower pediatric airway.</div></div>","PeriodicalId":94286,"journal":{"name":"CHEST pulmonary","volume":"3 2","pages":"Article 100120"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144243105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Overlooked Epidemic 被忽视的流行病
CHEST pulmonary Pub Date : 2025-06-01 DOI: 10.1016/j.chpulm.2025.100166
Sameer Khanijo MD
{"title":"The Overlooked Epidemic","authors":"Sameer Khanijo MD","doi":"10.1016/j.chpulm.2025.100166","DOIUrl":"10.1016/j.chpulm.2025.100166","url":null,"abstract":"","PeriodicalId":94286,"journal":{"name":"CHEST pulmonary","volume":"3 2","pages":"Article 100166"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144280190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bronchoscopic Lung Volume Reduction 支气管镜下肺减容
CHEST pulmonary Pub Date : 2025-06-01 DOI: 10.1016/j.chpulm.2024.100117
Domingo J. Franco-Palacios MD , Rebecca Priebe NP , Jane Simanovski PhD, NP , Lisa L. Allenspach MD , Lisa Stagner DO , Lisa K. Waynick PA , Yichu Wang BS , Mei Lu BS , Shraddha Desai MD , Daniel Kapadia MD , Avi Cohen MD
{"title":"Bronchoscopic Lung Volume Reduction","authors":"Domingo J. Franco-Palacios MD ,&nbsp;Rebecca Priebe NP ,&nbsp;Jane Simanovski PhD, NP ,&nbsp;Lisa L. Allenspach MD ,&nbsp;Lisa Stagner DO ,&nbsp;Lisa K. Waynick PA ,&nbsp;Yichu Wang BS ,&nbsp;Mei Lu BS ,&nbsp;Shraddha Desai MD ,&nbsp;Daniel Kapadia MD ,&nbsp;Avi Cohen MD","doi":"10.1016/j.chpulm.2024.100117","DOIUrl":"10.1016/j.chpulm.2024.100117","url":null,"abstract":"<div><h3>Background</h3><div>Many bronchoscopic lung volume reduction (BLVR) studies have excluded patients meeting the listing criteria for lung transplantation (LT).</div></div><div><h3>Research Question</h3><div>What are the outcomes of BLVR in a sicker group of patients with emphysema compared with patients not meeting the criteria for LT listing?</div></div><div><h3>Study Design and Methods</h3><div>This was a real-world retrospective study (June 2018 to December 2022) assessing the effect of BLVR in patients with severe emphysema considered for LT. FEV<sub>1</sub>, FVC, diffusing capacity for carbon monoxide, symptoms, and 6-minute walk distance (6-MWD) were measured at baseline and 45 days and 6 months after BLVR.</div></div><div><h3>Results</h3><div>Of 76 fully evaluated patients (median age, 62 years; 60% female), 42 underwent BLVR (30 sicker patients met the criteria for LT listing). At baseline, patients that met the criteria for listing had shorter baseline 6-MWD (234.72 ± 68.86, <em>P</em> &lt; .001), higher BODE Index score (6.79 ± 1.11, <em>P</em> = .001), and lower FEV<sub>1</sub> (617.5 ± 139.2 mL, <em>P</em> = .005). All patients treated with BLVR experienced a decrease in BODE Index and Borg dyspnea by scores −0.5 to −2 points, respectively. Diffusing capacity for carbon monoxide % predicted increased by 4.5%, FEV<sub>1</sub> increased by 115 mL, FVC increased by 450 mL, and 6-MWD increased by 20 meters. In the sicker group, FEV<sub>1</sub> at 45 days after BLVR increased by 180.8 ± 231 mL (FEV<sub>1</sub> % predicted 5.84 ± 5.66) compared with baseline; a persistent effect was seen at 6 months in 62% of patients with available data (18 of 30). Median hospital length of stay was 3.27 ± 3.07 days. Endobronchial valves were removed in 6 patients (3 in each group) due to complications. The pneumothorax rate was 24% (10 of 42; 5 in each group).</div></div><div><h3>Interpretation</h3><div>Improvement in lung function after BLVR was observed regardless of disease severity. BLVR might represent an alternative to LT for some patients.</div></div>","PeriodicalId":94286,"journal":{"name":"CHEST pulmonary","volume":"3 2","pages":"Article 100117"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144298043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cumulative Personal Radiation Exposure for a Single Pulmonary Proceduralist Over 1 Year 单个肺部手术医师1年以上个人累积辐射暴露
CHEST pulmonary Pub Date : 2025-06-01 DOI: 10.1016/j.chpulm.2025.100161
Kim Styrvoky MD , Xinhui Duan PhD
{"title":"Cumulative Personal Radiation Exposure for a Single Pulmonary Proceduralist Over 1 Year","authors":"Kim Styrvoky MD ,&nbsp;Xinhui Duan PhD","doi":"10.1016/j.chpulm.2025.100161","DOIUrl":"10.1016/j.chpulm.2025.100161","url":null,"abstract":"","PeriodicalId":94286,"journal":{"name":"CHEST pulmonary","volume":"3 2","pages":"Article 100161"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144243083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Risk Factors for Death in Older Adult Patients With TB in Japan 日本老年结核病患者死亡危险因素评估
CHEST pulmonary Pub Date : 2025-06-01 DOI: 10.1016/j.chpulm.2025.100162
Seigo Miyoshi MD, PhD, Mayuko Semba MD, Miyuki Tanabe MD, Chika Sato MD, Akira Watanabe MD, PhD, Ryoji Ito MD, PhD, Mari Kubota, Masahiro Abe MD, PhD
{"title":"Assessment of Risk Factors for Death in Older Adult Patients With TB in Japan","authors":"Seigo Miyoshi MD, PhD,&nbsp;Mayuko Semba MD,&nbsp;Miyuki Tanabe MD,&nbsp;Chika Sato MD,&nbsp;Akira Watanabe MD, PhD,&nbsp;Ryoji Ito MD, PhD,&nbsp;Mari Kubota,&nbsp;Masahiro Abe MD, PhD","doi":"10.1016/j.chpulm.2025.100162","DOIUrl":"10.1016/j.chpulm.2025.100162","url":null,"abstract":"<div><h3>Background</h3><div>Previous studies have identified several risk factors for death because of TB, including advanced age, HIV coinfection, multidrug-resistant TB, malnutrition, low activities of daily living, and comorbidities. In Japan, the incidence of TB and TB-related deaths is consistently higher among older individuals. However, few studies have evaluated the risk factors for death in older adult patients with TB.</div></div><div><h3>Research Question</h3><div>What are the risk factors for death among older adults with TB?</div></div><div><h3>Study Design and Methods</h3><div>This prospective cohort study included data on consecutive older adult patients (aged ≥ 65 years) who were admitted for treatment of TB between October 2016 and April 2022. We collected data on patient characteristics, chest radiography findings, and laboratory data and assessed whether these parameters were associated with patient death. We also examined the risk factors associated with TB-related and TB-unrelated deaths as a subanalysis.</div></div><div><h3>Results</h3><div>Multivariate Cox proportional hazards analysis showed that performance status (hazard ratio [HR], 1.434; 95% CI, 1.051-1.956; <em>P</em> = .023), corticosteroid use (HR, 2.679; 95% CI, 1.374-5.221; <em>P</em> = .004), and serum albumin levels (HR, 0.434; 95% CI, 0.235-0.804; <em>P</em> = .008) were significantly correlated with all-cause mortality. Subanalyses demonstrated that performance status was significantly correlated with TB-related death (HR, 2.048; 95% CI, 1.459-2.874; <em>P</em> &lt; 0.001), whereas advanced age (HR, 1.073; 95% CI, 1.008-1.142; <em>P</em> = .027), corticosteroid use (HR, 4.131; 95% CI, 1.783-9.575; <em>P</em> &lt; .001), and serum albumin levels (HR, 0.435; 95% CI, 0.225-0.842; <em>P</em> = .014) were significantly correlated with TB-unrelated deaths.</div></div><div><h3>Interpretation</h3><div>The evaluation of daily activity, physical ability, immune status, and nutritional status is considered an important factor directly related to prognosis in the treatment of TB in older adults. Large-scale prospective studies should be conducted in the future.</div></div>","PeriodicalId":94286,"journal":{"name":"CHEST pulmonary","volume":"3 2","pages":"Article 100162"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144243103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Canary in the Coalmine? 煤矿里的金丝雀?
CHEST pulmonary Pub Date : 2025-06-01 DOI: 10.1016/j.chpulm.2025.100155
William J. Healy MD , Younghoon Kwon MD
{"title":"Canary in the Coalmine?","authors":"William J. Healy MD ,&nbsp;Younghoon Kwon MD","doi":"10.1016/j.chpulm.2025.100155","DOIUrl":"10.1016/j.chpulm.2025.100155","url":null,"abstract":"","PeriodicalId":94286,"journal":{"name":"CHEST pulmonary","volume":"3 2","pages":"Article 100155"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144243255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dyspnea and Right-Sided Heart Failure in a Patient With a History of Pneumonectomy 有全肺切除术史患者的呼吸困难和右侧心力衰竭
CHEST pulmonary Pub Date : 2025-06-01 DOI: 10.1016/j.chpulm.2025.100149
Shelsey W. Johnson MD , Melanie C. Kwan MD , Sarah A.M. Cuddy MD , Aaron B. Waxman MD, PhD , Lida P. Hariri MD, PhD , William M. Oldham MD, PhD
{"title":"Dyspnea and Right-Sided Heart Failure in a Patient With a History of Pneumonectomy","authors":"Shelsey W. Johnson MD ,&nbsp;Melanie C. Kwan MD ,&nbsp;Sarah A.M. Cuddy MD ,&nbsp;Aaron B. Waxman MD, PhD ,&nbsp;Lida P. Hariri MD, PhD ,&nbsp;William M. Oldham MD, PhD","doi":"10.1016/j.chpulm.2025.100149","DOIUrl":"10.1016/j.chpulm.2025.100149","url":null,"abstract":"<div><h3>Case Presentation</h3><div>A 67-year-old man who never smoked was evaluated in the emergency department for 3 months of progressive dyspnea, lower extremity edema, and 20lb weight gain. Eighteen months before this, he had presented with hemoptysis and was ultimately found to have squamous cell lung cancer invading the left pulmonary artery without lymph node involvement, stage pT4N0M0, for which he underwent left pneumonectomy. His medical history was additionally notable for paroxysmal atrial fibrillation and factor V Leiden mutation (anticoagulated on apixaban). Social history was notable for work as a grocer in a supermarket; the patient denied history of asbestos exposure and had no known TB exposure or prior infection. The patient was admitted to general cardiology where he was afebrile, in atrial fibrillation with rapid ventricular response to 127 beats/min with associated hypotension (80/55 mm Hg); his oxygen saturation was 95% on room air. Physical examination was most notable for jugular venous distension and bilateral edema to the thigh. Electrocardiogram did not demonstrate ischemia. Laboratory evaluation demonstrated a creatinine level of 1.10 mg/dL, elevated from his recent baseline level of 0.52 mg/dL. Lactic acid was normal. His cardiac biomarkers were abnormal with an elevated N-terminal pro-B-type natriuretic peptide value (3,682 pg/mL) and high sensitivity troponin T (43 ng/L). Both WBC count and hemoglobin values were normal as were his thyroid hormone levels. IV diuretic and antiarrhythmic therapies were initiated with furosemide and amiodarone, respectively.</div></div>","PeriodicalId":94286,"journal":{"name":"CHEST pulmonary","volume":"3 2","pages":"Article 100149"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144279504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Connecting the Dots Between Asthma Control and Frailty in Older Adults With Moderate to Severe Asthma 中重度哮喘老年人哮喘控制与虚弱之间的联系
CHEST pulmonary Pub Date : 2025-06-01 DOI: 10.1016/j.chpulm.2025.100147
Ricardo G. Figueiredo PhD , Fernando Holguin MSc , Márcia M.M. Pizzichini PhD , Gabriela P. Pinheiro PhD , Vanessa Arata MD , Maisa F.M. Leal , Cinthia V.N. Santana PhD , José de Bessa Junior PhD , Álvaro A. Cruz PhD
{"title":"Connecting the Dots Between Asthma Control and Frailty in Older Adults With Moderate to Severe Asthma","authors":"Ricardo G. Figueiredo PhD ,&nbsp;Fernando Holguin MSc ,&nbsp;Márcia M.M. Pizzichini PhD ,&nbsp;Gabriela P. Pinheiro PhD ,&nbsp;Vanessa Arata MD ,&nbsp;Maisa F.M. Leal ,&nbsp;Cinthia V.N. Santana PhD ,&nbsp;José de Bessa Junior PhD ,&nbsp;Álvaro A. Cruz PhD","doi":"10.1016/j.chpulm.2025.100147","DOIUrl":"10.1016/j.chpulm.2025.100147","url":null,"abstract":"","PeriodicalId":94286,"journal":{"name":"CHEST pulmonary","volume":"3 2","pages":"Article 100147"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144261653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Multicenter Retrospective Study Evaluating IL-5-Targeted Biologic Therapies for the Treatment of Asthma and Allergic Bronchopulmonary Aspergillosis in Adults With Cystic Fibrosis 一项评估il -5靶向生物疗法治疗成人囊性纤维化患者哮喘和过敏性支气管肺曲菌病的多中心回顾性研究
CHEST pulmonary Pub Date : 2025-06-01 DOI: 10.1016/j.chpulm.2025.100163
Sameer Desai PhD , Sophia Shen MD , Zosia Gryz BSc , Elizabeth Tullis MD , Anne L. Stephenson MD, PhD , Bradley S. Quon MD, MSc
{"title":"A Multicenter Retrospective Study Evaluating IL-5-Targeted Biologic Therapies for the Treatment of Asthma and Allergic Bronchopulmonary Aspergillosis in Adults With Cystic Fibrosis","authors":"Sameer Desai PhD ,&nbsp;Sophia Shen MD ,&nbsp;Zosia Gryz BSc ,&nbsp;Elizabeth Tullis MD ,&nbsp;Anne L. Stephenson MD, PhD ,&nbsp;Bradley S. Quon MD, MSc","doi":"10.1016/j.chpulm.2025.100163","DOIUrl":"10.1016/j.chpulm.2025.100163","url":null,"abstract":"<div><h3>Background</h3><div>Biologic therapies targeting T-helper cell type 2 (Th2) eosinophilic inflammation have been used for difficult-to-treat asthma and allergic bronchopulmonary aspergillosis (ABPA), but safety and efficacy data are limited in the cystic fibrosis (CF) population.</div></div><div><h3>Research Question</h3><div>Are Th2 biologic therapies targeting eosinophilic inflammation effective and safe when used in adults with CF with asthma and/or ABPA overlap?</div></div><div><h3>Study Design and Methods</h3><div>This was a retrospective multicenter study. Individuals with CF receiving Th2 biologic therapies for asthma or ABPA at 2 large adult CF centers between 2016 and 2021 were included. Treatment safety and effectiveness up to 12 months after biologic initiation were evaluated. Outcomes of interest included percent predicted FEV<sub>1</sub> (ppFEV<sub>1</sub>), rate of change in ppFEV<sub>1</sub>, cumulative systemic corticosteroid (SCS) dose, and frequency of pulmonary exacerbations (PExs).</div></div><div><h3>Results</h3><div>Forty adults with CF received Th2 biologic therapies targeting eosinophilic inflammation during the study period. A total of 38 were eligible for study inclusion, and all received IL-5-directed therapies (mepolizumab: n = 27, benralizumab: n = 11): 17 (45%) for asthma only and 21 for ABPA (55%) with or without asthma. No significant biologic-related adverse effects were observed. There was no statistical difference in ppFEV<sub>1</sub> from baseline to 12-months postbiologic initiation, but the rate of change in ppFEV<sub>1</sub> improved in the 12 months postbiologic vs prebiologic with a pre-to-post difference of 3.7% (95% CI, 1.2%-6.3%). SCS dose and frequency of PExs requiring hospitalization did not differ significantly in the 12 months before biologic vs after biologic initiation.</div></div><div><h3>Interpretation</h3><div>Our results show that in adults with CF, anti-IL-5 biologic therapies were well tolerated and can improve rate of change in lung function, but there was no impact on SCS use or PEx frequency. Further study is needed to better define the role of Th2 biologics in the era of highly effective modulator therapy.</div></div>","PeriodicalId":94286,"journal":{"name":"CHEST pulmonary","volume":"3 2","pages":"Article 100163"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144243263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Li X, Tang Y, Chen C, Wang P, Shen Y. CHEST Pulmonary. 2023;1(2):100011. 李霞,唐勇,陈晨,王鹏,沈勇。胸肺杂志。2023;1(2):100011。
CHEST pulmonary Pub Date : 2025-06-01 DOI: 10.1016/j.chpulm.2025.100172
{"title":"Li X, Tang Y, Chen C, Wang P, Shen Y. CHEST Pulmonary. 2023;1(2):100011.","authors":"","doi":"10.1016/j.chpulm.2025.100172","DOIUrl":"10.1016/j.chpulm.2025.100172","url":null,"abstract":"","PeriodicalId":94286,"journal":{"name":"CHEST pulmonary","volume":"3 2","pages":"Article 100172"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144223454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信